Breast milk protein safely decreases infections in preemies

Image
ANI Washington D.C. [USA]
Last Updated : Oct 08 2016 | 1:32 PM IST

To reduce hospital-acquired infections in neonatal intensive care units, researchers have found a protein in breast milk to be a safe and efficient solution.

Lead author of the study Michael Sherman explained, "The majority of diseases affecting newborn preemies are hospital-acquired infections such as meningitis, pneumonia and urinary tract infections. Not only did we find that lactoferrin, a protein found in breast milk, could reduce hospital infections among preemies, but we also measured the safety of feeding the protein to newborns."

Sherman and his team conducted a randomized control trial with premature infants weighing between 1 pound, 10 ounces, and 3 pounds, 4 ounces, at birth.

Sixty of the infants were fed lactoferrin through a feeding tube twice a day for 28 days, while 60 additional infants were given a placebo.

Researchers found the rate of hospital-acquired infections was 50 percent lower among the infants fed lactoferrin.

In addition, the researchers used MedDRA, a system that reports safety outcomes to the U.S. Food and Drug Administration, to evaluate the safety of lactoferrin during and after the infants received the

protein.

Infants were examined for adverse effects from the protein six and 12 months after the trial ended.

Sherman said that all adverse effects identified were associated with complications from preterm birth and not lactoferrin.

"While a large-scale clinical trial is needed before lactoferrin becomes a standard treatment protocol in NICUs, our results show the safety of lactoferrin and provide an initial report of efficiency related to reducing hospital-acquired infections," Sherman said.

Lactoferrin can cost an estimated 25 dollar to 500 dollar per dose; a study published in the Journal of the American Medical Association found that hospital-acquired infections costs 9.8 billion dollar to

treat each year.

The study was published by The Journal of Pediatrics. Research reported in this publication was supported by the National Institutes of Health (HD05774).

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 08 2016 | 1:15 PM IST

Next Story